Student Fellow Alumna Lauren Taylor on the American Health Care Paradox: HMS Center for Bioethics Contemporary Authors in Bioethics Series

Center for Bioethics, Harvard Medical School, October 27, 2016

Lauren A. Taylor, MPH, MDiv will discuss her book,  The…

Read More

Drug Pricing: Where Do We Go After the Election?

Institute for Public Health, Washington University in St. Louis, October 26, 2016
Rachel Sachs

From the blog post: Martin Shkreli. Valeant Pharmaceuticals. Mylan. Just a year ago, most Americans devoted little time and attention to the question of pharmaceutical pricing. Now, after a series of highly publicized scandals involving individuals and companies who…

Read More

Rights, Nudging, and the Good of Others

16 American Journal of Bioethics 11, Published online October 17, 2016
Luke Gelinas (Petrie-Flom/Harvard Catalyst Fellow in Clinical Research Ethics)

Luke Gelinas, the Petrie-Flom/Harvard Catalyst Fellow in Clinical Research Ethics, has a new article commentary out in the American Journal of Bioethics responding to a new article (in the same issue) on The ethics of organ donor registration policies: Nudges and respect for autonomy by…

Read More

Issues With Tissues

16 American Journal of Bioethics 11, Published online October 17, 2016
Emily Largent (Student Fellow Alumna)

Student Fellow Alumna Emily Largent has a new article commentary out in the American Journal of Bioethics, in which she responds to a new article (in the same issue) on The ethics of organ donor registration policies: Nudges and respect for autonomy by Douglas McKay and Alexandra Robinson.…

Read More

Innovation–Innovation Tradeoffs in Drug Pricing

Annals of Internal Medicine, October 11, 2016
Rachel Sachs (Academic Fellow alumna)

From the article: The uproar over the price of the EpiPen is the latest episode in a longstanding controversy over drug pricing. A common concern is that proposed regulation of drug markets may reduce the rate of drug innovation and therefore decrease the number of…

Read More

Social Media Use in Research Recruitment: A New Guidance Document from Petrie-Flom and Harvard Catalyst

Petrie-Flom Center / Harvard Catalyst, September 21, 2016
Luke Gelinas (Petrie-Flom/Harvard Catalyst Fellow in Clinical Research Ethics)

Cross-posted at the Petrie-Flom Center's blog Bill of Health. Imagine this scenario: you are a researcher conducting a clinical trial on a promising treatment for a rare but serious heart condition. Unfortunately,…

Read More

Professor offers basics of bioethics and the law in 90 minutes: Harvard expert breaks down complex topic for Ed Portal and online audience

Harvard Gazette, September 20, 2016
Deborah Blackwell, reviewing lecture by I. Glenn Cohen (Faculty Director)

On September 13, 2016, Petrie-Flom Faculty Director I. Glenn Cohen delivered a lecture at the Harvard Ed Portal as part of his online EdX course "Bioethics: The Law, Medicine, and Ethics of Reproductive Technologies…

Read More

Is Medical Tourism Ethical?: Profile of I. Glenn Cohen's work as a Greenwall Foundation Faculty Scholar

The Greenwall Foundation, September 2016

Petrie-Flom Faculty Director I. Glenn Cohen served as a Greenwall Foundation Faculty Scholar, Class of 2015. The Greenwall Foundation recently published a profile of Cohen's project, "Is…

Read More

The morality of risks in research: reflections on Kumar

Journal of Medical Ethics, September 19, 2016 (online first)
Frances M. Kamm (Senior Fellow alumna)

Abstract: Reflecting on the contribution by Rahul Kumar to the symposium, I consider the following topics in relation to risks in research: (1) treating someone as a mere means; (2) aggregation; (3) different conceptions of contractualism; (4) uncertainty; (5) paternalism and complicity.

Read More

EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future

Journal of Law and the Biosciences, September 16, 2016
Emily A. Largent (Student Fellow alumna)

Abstract: In 2014, West Africa confronted the most severe outbreak of Ebola virus disease (EVD) in history. At the onset of the outbreak—as now—there were no therapies approved by the U.S. Food and Drug Administration (FDA) for prevention of, post-exposure prophylaxis against,…

Read More

Bioethics and the Law of Reproductive Technology and Genetics: Free Public Lecture by Faculty Director I. Glenn Cohen

Harvard Ed Portal, Allston, MA, September 13, 2016

Genetic enhancements. Reproductive technologies. Animal-human hybrids. Through new technologies and discoveries in science, we are able to do amazing things. However, these new developments have brought many questions to the surface as bioethics and the law intersect.   Join Harvard…

Read More

Federal Government’s Proposed Expansion of Regulation of Biospecimen Research Should Be Reconsidered: New Commentary from Petrie-Flom Fellowship Alumnus Christopher T. Robertson

Biopreservation and Biobanking, September 2016
Christopher T. Robertson and Jonathan D. Loe

Note: The full article is behind a paywall. Abstract: In September, the U.S. Department of Health and Human Services, together with other federal agencies, announced proposed changes to the rules governing human subjects research. This Commentary discusses…

Read More

Bioethics: The Law, Medicine, and Ethics of Reproductive Technologies and Genetics: New EdX Course from Faculty Director Glenn Cohen

Petrie-Flom Center, Course begins September 6, 2016. Register now!

Bioethics: The Law, Medicine, and Ethics of Reproductive Technologies and Genetics An introduction to the study of bioethics and the application of legal and ethical reasoning. Course begins on September 6, 2016. Register…

Read More

Big Data Neglects Populations Most in Need of Medical and Public Health Research and Interventions

Arizona Legal Studies Discussion Paper, No. 16-26, August 18, 2016
Sarah E. Malanga, Jonathan D. Loe, Christopher T. Robertson (Academic Fellow alumnus), and Kenneth S. Ramos

Originally presented as a paper at the 2016 Petrie-Flom Center Annual Conference: Big Data, Health Law, and Bioethics. Check out the event website to watch video of this and other presentations! …

Read More

The FDA is prohibited from going germline

Science, August 5, 2016
I. Glenn Cohen (Faculty Director) and Eli Y. Adashi

Petrie-Flom Faculty Director I. Glenn Cohen has co-authored a new article in Science magazine addressing recent legislation preventing the FDA from approving any research "in which a human embryo…

Read More

Medical Assistance in Dying and ‘Suicide Tourism’ to Canada: Bill C-14 from a Comparative Perspective

Journal of Ethics in Mental Health, July 31, 2016
Konstanin Tretyakov and I. Glenn Cohen (Faculty Director)

Bill C-14 was introduced by the government of Canada in the aftermath of the Supreme Court’s decision which legalized physician-assisted dying in Canada. This article compares the Bill with the decision of the Supreme Court (Carter v. Canada (Attorney General)) and tracks some of the important…

Read More

Vaccines and Airline Travel:: A Federal Role to Protect the Public Health

42 American Journal of Law and Medicine 543, (2016)
Christopher T. Robertson (Academic Fellow Alumnus)

Abstract: This Article explores two ways in which airline travel is an important vector for the spread of infectious disease, and argues that airlines have market-based and liability-based reasons to require that passengers be vaccinated. Going further, the Article explores whether…

Read More

Bosses in the Bedroom: Religious Employers and the Future of Employer-Sponsored Health Care

Law, Religion, and Health in the United States (Holly Fernandez Lynch, I. Glenn Cohen, Elizabeth Sepper, eds.), forthcoming 2017, Cambridge University Press, 2017 (forthcoming)
Holly Fernandez Lynch (Executive Director) and Gregory Curfman

Abstract:       This chapter uses the controversy over mandated contraceptive coverage in employer health plans as a jumping-off point to do two things: (1) evaluate the proper scope of religion in…

Read More

Embryo Disposition Disputes: Controversies and Case Law

Hastings Center Report, July/August 2016, Vol. 46, Issue 5
I. Glenn Cohen (Faculty Director) & Eli Y. Adashi

Abstract: When prospective parents use in vitro fertilization, many of them hope to generate more embryos than they intend to implant immediately. The technology often requires multiple attempts to reach a successful pregnancy, and couples can cryopreserve any excess embryos so that they have…

Read More

Religion and Reproductive Technology

In Law, Religion, and Health in the United States (Holly Fernandez Lynch, I. Glenn Cohen, Elizabeth Sepper, eds.), forthcoming 2017, Cambridge University Press, 2017 (forthcoming)
I. Glenn Cohen (Faculty Director)

Abstract: This chapter will examines places where law, religion, and reproductive technology conflict. It examines four particular intersections: The first involves religiously motivated denials of service, in particular as they pertain to single and gay and lesbian couples. The second involves…

Read More